SBFM Key Statistics, Chart & Performance
The current stock price of SBFM is 1.23 USD. In the past month the price decreased by -6.11%. In the past year, price decreased by -57.14%.
SBFM Technical Analysis
SBFM Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to SBFM. The financial health of SBFM is average, but there are quite some concerns on its profitability.
SBFM Financial Highlights
Over the last trailing twelve months SBFM reported a non-GAAP Earnings per Share(EPS) of -51.88. The EPS increased by 88.82% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -19.03% | ||
| ROE | -24.76% | ||
| Debt/Equity | 0 |
SBFM Forecast & Estimates
7 analysts have analysed SBFM and the average price target is 6.12 USD. This implies a price increase of 397.56% is expected in the next year compared to the current price of 1.23.
For the next year, analysts expect an EPS growth of 98.01% and a revenue growth -0.21% for SBFM
SBFM Ownership
About SBFM
Company Profile
Sunshine Biopharma, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of oncology and antiviral drugs. The company is headquartered in Fort Lauderdale, Florida and currently employs 52 full-time employees. The company went IPO on 2008-08-15. The firm has approximately 70 generic prescription drugs on the market in Canada. In addition, the Company is conducting a proprietary drug development program which is comprised of K1.1 mRNA, an mRNA-Lipid Nanoparticle targeted for liver cancer, and PLpro protease inhibitor, a small molecule for the treatment of SARS Coronavirus infections. The firm operates through two segments: Prescription Generic Pharmaceuticals (Generic Pharmaceuticals) and Nonprescription Over-The-Counter Products (OTC Products). The firm operates two wholly owned subsidiaries: Nora Pharma Inc., which has a portfolio of pharmaceutical products consisting of various prescription drugs on the market in Canada, and Sunshine Biopharma Canada Inc., which develops and sells nonprescription over-the-counter (OTC) products.
Company Info
SUNSHINE BIOPHARMA INC
333 Las Olas Way, Cu4 Suite 433
FORT LAUDERDALE FLORIDA US
Employees: 52
Phone: 19543300684
SUNSHINE BIOPHARMA INC / SBFM FAQ
Can you describe the business of SUNSHINE BIOPHARMA INC?
Sunshine Biopharma, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of oncology and antiviral drugs. The company is headquartered in Fort Lauderdale, Florida and currently employs 52 full-time employees. The company went IPO on 2008-08-15. The firm has approximately 70 generic prescription drugs on the market in Canada. In addition, the Company is conducting a proprietary drug development program which is comprised of K1.1 mRNA, an mRNA-Lipid Nanoparticle targeted for liver cancer, and PLpro protease inhibitor, a small molecule for the treatment of SARS Coronavirus infections. The firm operates through two segments: Prescription Generic Pharmaceuticals (Generic Pharmaceuticals) and Nonprescription Over-The-Counter Products (OTC Products). The firm operates two wholly owned subsidiaries: Nora Pharma Inc., which has a portfolio of pharmaceutical products consisting of various prescription drugs on the market in Canada, and Sunshine Biopharma Canada Inc., which develops and sells nonprescription over-the-counter (OTC) products.
Can you provide the latest stock price for SUNSHINE BIOPHARMA INC?
The current stock price of SBFM is 1.23 USD. The price decreased by -1.6% in the last trading session.
Does SUNSHINE BIOPHARMA INC pay dividends?
SBFM does not pay a dividend.
How is the ChartMill rating for SUNSHINE BIOPHARMA INC?
SBFM has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
How is the valuation of SUNSHINE BIOPHARMA INC (SBFM) based on its PE ratio?
SUNSHINE BIOPHARMA INC (SBFM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-51.88).
What is the employee count for SBFM stock?
SUNSHINE BIOPHARMA INC (SBFM) currently has 52 employees.
What is SUNSHINE BIOPHARMA INC worth?
SUNSHINE BIOPHARMA INC (SBFM) has a market capitalization of 6.04M USD. This makes SBFM a Nano Cap stock.